drugset / Trial / NCT01887626

Study to Investigate if the Uptake of Ticagrelor Into the Body Differs Depending on Method of Administration.

NCT01887626

Phase 1 Completed 36 enrolled AstraZeneca
RandomizedCrossoverOpen-labelBasic science

Summary

Study to investigate if the uptake of Ticagrelor into the body differs depending on method of administration.

Timeline

Start
2013-07
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Ticagrelor Small molecule 90 mg Oral

Indications

No indication recorded.